| Cell permeable, potent, and selective proteasome inhibitor. More potent than Lactocystin. Inhibits the chymotrypsin-like, trypsin-like, and peptidylglutamyl peptide-hydrolyzing activities of the proteasome. | |
| Reference Price: | $130.00 Click to Order |
| More Information: | BU-4061T - CAS [1404-0402] - C28H50N4O7 - Cancer Research - Antibiotic - Meng, L. et al. - Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity - PNAS. - Sin, N. et al. - Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology. - Bioorg. Med. Chem. Lett. - Hanada, M., et al. - Epoxomicin, a new antitumor agent of microbial origin. - J. Antibiot. |
Return to Home Page
Powered By SmartWin Technology eCommerce Software